![](/img/cover-not-exists.png)
S86 Results from the first phase I clinical study of the novel Ii-Key/HER-2(776–790) hybrid peptide vaccine in patients with prostate cancer
S. Mpisias, T. Kalogeropoulos, E. Koutsiaris, A. Rempelakos, A. Konandreas, K. Georgakopoulou, S. Perez, K. Baxevanis, T. Arvanitakis, A. ThanosVolume:
8
Year:
2009
Language:
english
DOI:
10.1016/s1569-9056(09)74967-x
File:
PDF, 95 KB
english, 2009